CliniCian’s Corner

Case 1: Persistent fever in a
toddler

A

previously well 20-month-old girl, with a two-week history of
persistent fever and neutropenia, was transferred from a secondary care hospital for investigation to rule out a possible diagnosis of
leukemia. There was no history of infectious contacts or viral prodrome. The patient previously visited the family physician and emergency room on days 3, 7 and 12 of the fever, and was diagnosed with
acute otitis media. She was treated with clarithromycin until day 7,
when she was switched to amoxicillin due to continued fever.
The medical history revealed a fully immunized, healthy child
of Asian descent who, at nine months of age, developed a maculopapular rash following seven days of treatment with amoxicillin
and ibuprofen for acute otitis media.

A physical examination revealed an irritable child with a
fever of 40°C, a new-onset generalized erythematous maculopapular rash and a palpable spleen, but no lymphadenopathy.
The remainder of the examination was unremarkable.
Specifically, there were no findings of nonpurulent conjunctivitis, oral-mucosal changes, cervical lymphadenopathy, palmar
or plantar changes, cardiac murmur or arthritis.
The initial workup revealed pancytopenia (absolute neutrophil
count 0.2×109/L, hemoglobin 70 g/L, platelets 119×109/L), hypoalbuminemia, an elevated erythrocyte sedimentation rate (ESR),
an elevated C-reactive protein (CRP) level, a positive EpsteinBarr virus (EBV) polymerase chain reaction (12,100 copies
detected) and splenomegaly on abdominal ultrasound. Bone marrow biopsy and hemoglobin electrophoresis findings were normal.
Other negative test results for infections included urine, blood and
stool cultures, and serology for cytomegalovirus, varicella, hepatitis A, B and C, and HIV I and II.
Because of a possible penicillin allergy, she was empirically
treated with vancomycin and meropenem, which were discontinued following negative blood and urine cultures. She was also
transfused with packed red blood cells and albumin because of low
hemoglobin and albumin levels. The patient improved clinically
and was discharged on day 21 of fever onset. She was febrile but
clinically stable. The diagnosis was believed to be EBV infection
and a subsequent hypersensitivity vasculitis reaction to penicillin.
The toddler initially improved, then worsened with new-onset
jaundice, irritability and hepatomegaly. She returned five days
later with the following laboratory findings: pancytopenia (absolute neutrophil count 0.4×109/L, hemoglobin 76 g/L, platelets
24×109/L), hypertriglyceridemia (12.4 mmol/L), hypofibrinogenemia (1.56 g/L), hyperferritinemia (1230 µg/L), hyperbilirubinemia (68.7 µmol/L), transaminitis (alanine aminotransferase
313 U/L, aspartate aminotransferase 1507 U/L), coagulopathy
(international normalized ratio 1.2, partial thromboplastin time
67 s) and a lactate dehydrogenase level of 5364 U/L. Her CRP
level increased from 42 mg/L to 56 mg/L but her ESR decreased
from 62 mm/h to 16 mm/h.
A diagnosis was made based on the clinical findings and laboratory test results.
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Clinician’s Corner

Case 1 diagnosis:
hemophagoCytiC LymphohistioCytosis
assoCiated with eBV infeCtion

In a child with prolonged fever, it is important to consider a broad
range of differential diagnoses including infectious diseases
(eg, endocarditis), rheumatological conditions (eg, Kawasaki disease and systemic juvenile idiopathic arthritis) and oncological
conditions (eg, leukemia). All of the above were considered and
tested for in our toddler, but her clinical presentation and blood
work were indicative of hemophagocytic lymphohistiocytosis
(HLH).
HLH has been well described in association with EBV infections. Although rare, it is probably underdiagnosed. For a diagnosis
of HLH, at least five major, or four major and one alternative
diagnostic criteria must be fulfilled.
major diagnostic criteria
• Fever (higher than 38.5°C for seven days or longer).
• Splenomegaly (more than 3 cm below the left costal margin).
• Cytopenia (two or more cell lines involved).
• Hypertriglyceridemia (fasting triglycerides greater than
2.0 mmol/L) and/or hypofibrinogenemia (lower than 1.5 g/L).
• Hemophagocytosis in bone marrow, spleen or lymph nodes.
alternative diagnostic criteria
• Low or absent natural killer cells.
• High serum ferritin level (greater than 500 µg/L) and high
soluble CD25 level (greater than 2400 U/mL).
HLH is divided into familial and reactive types. Familial HLH
has been associated with an autosomal recessive inheritance with
genes located on chromosomes 9 and 10. Reactive HLH may occur
when an underlying infection triggers the body’s autoimmune
response, leading to hemophagocytosis. However, familial and
reactive HLH can be difficult to differentiate because many cases
of familial HLH are triggered by viral infections.
The clinical manifestations of HLH vary according to the underlying infection, but the main features include fever, splenomegaly,
hepatomegaly, lymphadenopathy, nonspecific rash and neurological
signs. Laboratory findings include pancytopenia, hypertriglyceridemia, hyperferritinemia, transaminitis and hypofibrinogenemia. It
is crucial to monitor the trends of these laboratory parameters along
with clinical correlation if HLH is suspected. Hemophagocytosis
can be found in bone marrow, spleen, lymph nodes, liver, hepatic
portal tracts and, rarely, in the central nervous system and skin
resulting in pancytopenia. Of note, the first bone marrow biopsy
might not always show evidence of hemophagocytosis.
Because the disease is rare, no controlled clinical trials on treatment protocols have been performed. If left untreated, EBVassociated HLH may result in death from hemorrhage, infection or
multiorgan failure. Before the HLH protocol in 1994, HLH was
associated with 90% mortality. Currently, there is an estimated
55% survival rate at three-year follow-up. Treatment according to
the HLH protocol includes induction with dexamethasone, cyclosporine and etoposide. Occasionally, intrathecal methotrexate is
used if neurological symptoms are present. Bone marrow transplants have been performed in some cases. It is important to identify whether HLH is familial or reactive because the familial form
requires the full HLH protocol. For reactive HLH, treatment may
include part of the HLH protocol as well as supportive therapies
such as steroids, intravenous immunoglobulin and biological
agents. For EBV-associated HLH, concurrent antiviral therapy
may be required.
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In hindsight, our patient’s hypoalbuminemia and anemia
requiring transfusion were atypical for her initial diagnosis of EBV
infection and hypersensitivity to penicillin. Our patient was
treated using the HLH chemotherapy protocol and supportive
therapies including biological agents; however, she succumbed to
her disease at day 40 of fever due to hemorrhage and multiorgan
failure. The present case highlights the fact that HLH, specifically
EBV-associated HLH, remains a diagnostic challenge for clinicians. The current HLH-2004 protocol has improved survival;
however, patients with this disease continue to have high morbidity and mortality rates. Early suspicion of the diagnosis and referral
to a tertiary care centre is indicated.

CLiniCaL pearLs
• In an unwell child with prolonged fever, hepatosplenomegaly,
lymphadenopathy, rash and laboratory evidence of progressive
pancytopenia and liver dysfunction, consider HLH.
• Helpful laboratory tests include complete blood count,
triglyceride, fibrinogen, ferritin and liver function tests. Of
note in HLH, while CRP levels continue to rise, the ESR
trends down with disease progression related to decreased
fibrinogen. Early suspicion and diagnosis followed by prompt
transfer to a tertiary care setting for immediate treatment,
including chemotherapy, can improve survival rates.
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